Search - tctmd.com

Displaying 321 - 340 of 665

Sort: Relevancy | Date

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

In-Hospital Complications, Mortality High With Lead Extractions for Device Infections

Todd Neale

November 06, 2019

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Daily News

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Michael O'Riordan

October 22, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

Presenter: Hitinder Gurm

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

Presentation TCT 2019

TCT 32: Clinical Outcomes of Imaging- and Physiology-guided PCI without Contrast Administration in Advanced Renal Failure

Presenter: Hussein Rahim

September 25, 2019

Presentation TCT 2019

TCT 31: Use of Iso-Osmolar Contrast Media in High AKI Risk Patients Undergoing Peripheral Revascularization Procedures Is Associated with Lower Incidence of Major Adverse Renal or Cardiac Events (MARCE)

Presenter: Anand Prasad

September 25, 2019

Advertisement

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

In-Hospital Complications, Mortality High With Lead Extractions for Device Infections

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

TCT 32: Clinical Outcomes of Imaging- and Physiology-guided PCI without Contrast Administration in Advanced Renal Failure

TCT 31: Use of Iso-Osmolar Contrast Media in High AKI Risk Patients Undergoing Peripheral Revascularization Procedures Is Associated with Lower Incidence of Major Adverse Renal or Cardiac Events (MARCE)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content